Interventional cardiology has reduced difficulties for patients by providing speedy recovery, minimal hospital stays, and regulated bleeding.

SEATTLE, WASHINGTON, UNITED STATES, December 8, 2021 /EINPresswire.com/ -- Another factual information on the "Interventional Cardiology Devices Market" has as of late added by CMI to its storehouse. This research report offers an inside and out examination of various perspectives, for example, market patterns, pieces of the overall industry, drivers, restrictions, opportunities. It gives an investigative view to settle on further choices in organizations. It covers comprehensive instructive information of various key players working over the globe.

Request PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/691

Interventional cardiology has reduced difficulties for patients by providing speedy recovery, minimal hospital stays, and regulated bleeding. Interventional cardiology devices are constantly evolving, such as from bare-metal stents to bio-absorbable stents.

The global interventional cardiology devices market is worth US$ 27,745.6 million in 2020 and is expected to increase to US$ 45,754.1 million by 2027.

Global Interventional Cardiology Devices Market: Drivers

The approvals and release of new devices are expected to propel the global interventional cardiology devices market growth during the forecast period. For instance, Abbott Laboratories obtained U.S. Food and Drug Administration approval for XIENCE Sierra, a new generation of Everolimus-eluting coronary stents, in May 2018. In April 2018, Japan's regulatory authorities approved XIENCE.

Global Interventional Cardiology Devices Market: Opportunities

Research and development in interventional cardiology devices are expected to provide attractive growth prospects for global interventional cardiology devices market players. For instance, according to the analyses of the single-blind, randomized, noninferiority DEBUT trial, which was conducted by Harvard Medical School researchers and released in The Lancet in May 2019, PCI with drug-eluting balloons is non-inferior to PCI with bare-metal stents for the therapies of de novo coronary artery lesions in patients at high bleeding risk.

Global Interventional Cardiology Devices Market: Restraints

Device rising prices are expected to hamper the global interventional cardiology devices market growth over the forecast period. For instance, in April 2019, the National Pharmaceutical Pricing Authority (NPPA) approved a 4.2 % increase in the price of cardiac stents in line with the wholesale pricing index (WPI) in 2018.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/691

Key Takeaways:

The global interventional cardiology devices market was worth US$ 25,847.2 million in 2019 and is expected to increase to US$ 45,754.1 million by 2027 growing at a CAGR of 7.4% during the forecast period 2020 - 2027. Technological advancement and increased product launches are major factors driving the growth of the global interventional cardiology devices market over the forecast period.

Stents accounted for a major share in the global interventional cardiology devices market in 2019, representing 84.5 % of the market share, trailed by PTCA Guidewires and Angiography Catheters, respectively. Product launches in the stents market are supporting the segment's growth.

Market Trends:

Key players in the global interventional cardiology devices market are focusing on product approvals and release to grow their product offering. For instance, in September 2019, OrbusNeich Medical K.K., a Japanese company, obtained approval from the Japan Ministry of Health, Labor, and Welfare for their COMBO Plus Coronary Stent (MHLW).

Key players in the global interventional cardiology devices market are also focusing on research and development in order to extend their product range. For instance, Boston Scientific announced positive results for the Eluvia Drug-Eluting Vascular Stent for the treatment of femoropopliteal illness in November 2019.

Global Interventional Cardiology Devices Market: Competitive Landscape

Key players contributing to the global interventional cardiology devices market are SINOMED, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG., Terumo Medical Corporation, Biotronik SE & Co. KG, Cardinal Health, Abbott Laboratories, and Cook Medical.

Global Interventional Cardiology Devices Market: Key Developments

Key players in the global interventional cardiology devices market are focusing on product approvals and release to grow their product offering. For instance, in February 2019, Biotronik SE & Co. KG obtained U.S. Food and Drug Administration approval for its drug-eluting stent system for treating coronary artery disease. The DES is utilized in PCI to elute sirolimus via a bioabsorbable polymer layer.

Segmentation

By Device

Angiography Catheters

IVUS

PTCA Guidewires

Guiding Catheters

Balloon Inflation Devices

Stents

By End User

Hospitals

Clinics

Ambulatory Surgical Centers

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Buy This Research Study Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/691

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Interventional Cardiology Devices Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Interventional Cardiology Devices Industry Impact

Chapter 2 Interventional Cardiology Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Interventional Cardiology Devices (Volume and Value) by Type
2.3 Interventional Cardiology Devices (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Interventional Cardiology Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Interventional Cardiology Devices Market Analysis
Chapter 6 East Asia Interventional Cardiology Devices Market Analysis
Chapter 7 Europe Interventional Cardiology Devices Market Analysis
Chapter 8 South Asia Interventional Cardiology Devices Market Analysis
Chapter 9 Southeast Asia Interventional Cardiology Devices Market Analysis
Chapter 10 Middle East Interventional Cardiology Devices Market Analysis
Chapter 11 Africa Interventional Cardiology Devices Market Analysis
Chapter 12 Oceania Interventional Cardiology Devices Market Analysis
Chapter 13 South America Interventional Cardiology Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Interventional Cardiology Devices Business
Chapter 15 Interventional Cardiology Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+91 88494 80752
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other